IL127542A0 - Administration regimen of H+ K+ -ATPase inhibitors - Google Patents

Administration regimen of H+ K+ -ATPase inhibitors

Info

Publication number: IL127542A0
Authority: IL; Israel
Prior art keywords: administration regimen; atpase inhibitors; atpase; extended; profile
Prior art date: 1996-06-20

Application number

IL12754297A

Other languages

English (en)

Original Assignee

Astra Ab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-06-20

Filing date

1997-06-18

Publication date

1999-10-28

1997-06-18 Application filed by Astra Ab filed Critical Astra Ab

1999-10-28 Publication of IL127542A0 publication Critical patent/IL127542A0/xx

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

Health & Medical Sciences (AREA)
General Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Organic Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Enzymes And Modification Thereof (AREA)
Medicinal Preparation (AREA)
Medicines Containing Plant Substances (AREA)
Plural Heterocyclic Compounds (AREA)

IL12754297A 1996-06-20 1997-06-18 Administration regimen of H+ K+ -ATPase inhibitors IL127542A0 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
SE9602442A SE9602442D0 (sv)	1996-06-20	1996-06-20	Administration of pharmaceuticals
PCT/SE1997/001098 WO1997048380A1 (en)	1996-06-20	1997-06-18	ADMINISTRATION REGIMEN OF H+, K+-ATPase INHIBITORS

Publications (1)

Publication Number	Publication Date
IL127542A0 true IL127542A0 (en)	1999-10-28

Family

ID=20403092

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
IL12754297A IL127542A0 (en)	1996-06-20	1997-06-18	Administration regimen of H+ K+ -ATPase inhibitors
IL127542A IL127542A (en)	1996-06-20	1998-12-13	H+, K+-ATPase INHIBITORS FOR USE IN IMPROVED INHIBITION OF GASTRIC ACID SECRETION

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
IL127542A IL127542A (en)	1996-06-20	1998-12-13	H+, K+-ATPase INHIBITORS FOR USE IN IMPROVED INHIBITION OF GASTRIC ACID SECRETION

Country Status (28)

Country	Link
US (4)	US20010008900A1 (uk)
EP (1)	EP0921787B1 (uk)
JP (1)	JP2000512993A (uk)
CN (1)	CN1178648C (uk)
AT (1)	ATE252885T1 (uk)
AU (1)	AU726859B2 (uk)
BR (1)	BR9709838A (uk)
CA (1)	CA2257405A1 (uk)
CZ (1)	CZ298213B6 (uk)
DE (1)	DE69725860T2 (uk)
DK (1)	DK0921787T3 (uk)
EE (1)	EE04606B1 (uk)
ES (1)	ES2208921T3 (uk)
HK (1)	HK1018590A1 (uk)
HU (1)	HUP9901794A3 (uk)
IL (2)	IL127542A0 (uk)
IS (1)	IS2216B (uk)
NO (1)	NO323295B1 (uk)
NZ (1)	NZ332990A (uk)
PL (1)	PL189716B1 (uk)
PT (1)	PT921787E (uk)
RS (1)	RS49590B (uk)
RU (1)	RU2203662C2 (uk)
SE (1)	SE9602442D0 (uk)
SK (1)	SK284204B6 (uk)
TR (1)	TR199802647T2 (uk)
UA (1)	UA64715C2 (uk)
WO (1)	WO1997048380A1 (uk)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5945124A (en) *	1995-07-05	1999-08-31	Byk Gulden Chemische Fabrik Gmbh	Oral pharmaceutical composition with delayed release of active ingredient for pantoprazole
US5840737A (en)	1996-01-04	1998-11-24	The Curators Of The University Of Missouri	Omeprazole solution and method for using same
US6489346B1 (en)	1996-01-04	2002-12-03	The Curators Of The University Of Missouri	Substituted benzimidazole dosage forms and method of using same
US5968547A (en)	1997-02-24	1999-10-19	Euro-Celtique, S.A.	Method of providing sustained analgesia with buprenorphine
GB9720061D0 (en)	1997-09-19	1997-11-19	Crosfield Joseph & Sons	Metal compounds as phosphate binders
SE9704870D0 (sv)	1997-12-22	1997-12-22	Astra Ab	New pharmaceutical formulation I
SE9704869D0 (sv) *	1997-12-22	1997-12-22	Astra Ab	New pharmaceutical formulaton II
CA2330139A1 (en) *	1998-04-30	1999-11-04	Sepracor Inc.	R-rabeprazole compositions and methods
JP2002512263A (ja) *	1998-04-30	2002-04-23	セプラコール，インク．	Ｓ−レイブプラゾール組成物及び方法
US6093734A (en) *	1998-08-10	2000-07-25	Partnership Of Michael E. Garst, George Sachs, And Jai Moo Shin	Prodrugs of proton pump inhibitors
NZ510180A (en)	1998-08-10	2002-11-26	Univ California	Prodrugs of the pyridyl-methylsulphonyl-benzimidazole type proton pump inhibitors
US7041313B1 (en)	1998-08-12	2006-05-09	Altana Pharma Ag	Oral administration form for pyridin-2-ylmethylsulfinyl-1H-benzimidazoles
US20050048077A1 (en) *	2002-02-21	2005-03-03	George Sachs	Compositions, test kits and methods for detecting helicobacter pylori
MY148805A (en) *	2002-10-16	2013-05-31	Takeda Pharmaceutical	Controlled release preparation
US8993599B2 (en)	2003-07-18	2015-03-31	Santarus, Inc.	Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
TWI372066B (en)	2003-10-01	2012-09-11	Wyeth Corp	Pantoprazole multiparticulate formulations
US8906940B2 (en)	2004-05-25	2014-12-09	Santarus, Inc.	Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
CA2570916C (en)	2004-06-16	2013-06-11	Tap Pharmaceutical Products, Inc.	Pulsed release dosage form of a ppi
MY157620A (en)	2006-01-31	2016-06-30	Cytochroma Dev Inc	A granular material of a solid water-soluble mixed metal compound capable of binding phosphate
GB0714670D0 (en)	2007-07-27	2007-09-05	Ineos Healthcare Ltd	Use
GB0720220D0 (en)	2007-10-16	2007-11-28	Ineos Healthcare Ltd	Compound
GB0913525D0 (en)	2009-08-03	2009-09-16	Ineos Healthcare Ltd	Method
GB201001779D0 (en)	2010-02-04	2010-03-24	Ineos Healthcare Ltd	Composition

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB2189699A (en) *	1986-04-30	1987-11-04	Haessle Ab	Coated acid-labile medicaments
US5330982A (en) *	1986-12-17	1994-07-19	Glaxo Group Limited	Pharmaceutical composition containing a 5-HT receptor antagonist and an H+ K+ Atpase inhibitor and a method of treating gastrointestingal disorders therewith
CA2161256C (en) *	1993-04-27	2004-06-29	Nancy M. Gray	Methods and compositions for treating gastric disorders using optically pure (-) pantoprazole
SE9402431D0 (sv) *	1994-07-08	1994-07-08	Astra Ab	New tablet formulation
DK0723436T3 (da) *	1994-07-08	2001-11-26	Astrazeneca Ab	Tabletteret flerenhedsdoseringsform
US5945124A (en) *	1995-07-05	1999-08-31	Byk Gulden Chemische Fabrik Gmbh	Oral pharmaceutical composition with delayed release of active ingredient for pantoprazole
US6132768A (en) *	1995-07-05	2000-10-17	Byk Gulden Lomberg Chemische Fabrik Gmbh	Oral pharmaceutical composition with delayed release of active ingredient for reversible proton pump inhibitors

1996
- 1996-06-20 SE SE9602442A patent/SE9602442D0/xx unknown
1997
- 1997-06-18 CZ CZ0420398A patent/CZ298213B6/cs not_active IP Right Cessation
- 1997-06-18 IL IL12754297A patent/IL127542A0/xx active IP Right Grant
- 1997-06-18 SK SK1655-98A patent/SK284204B6/sk not_active IP Right Cessation
- 1997-06-18 JP JP10502822A patent/JP2000512993A/ja active Pending
- 1997-06-18 US US08/945,425 patent/US20010008900A1/en not_active Abandoned
- 1997-06-18 WO PCT/SE1997/001098 patent/WO1997048380A1/en active IP Right Grant
- 1997-06-18 AU AU34690/97A patent/AU726859B2/en not_active Ceased
- 1997-06-18 AT AT97930933T patent/ATE252885T1/de not_active IP Right Cessation
- 1997-06-18 TR TR1998/02647T patent/TR199802647T2/xx unknown
- 1997-06-18 NZ NZ332990A patent/NZ332990A/xx unknown
- 1997-06-18 DK DK97930933T patent/DK0921787T3/da active
- 1997-06-18 UA UA99010150A patent/UA64715C2/uk unknown
- 1997-06-18 BR BR9709838A patent/BR9709838A/pt not_active Application Discontinuation
- 1997-06-18 EP EP97930933A patent/EP0921787B1/en not_active Expired - Lifetime
- 1997-06-18 PT PT97930933T patent/PT921787E/pt unknown
- 1997-06-18 ES ES97930933T patent/ES2208921T3/es not_active Expired - Lifetime
- 1997-06-18 HU HU9901794A patent/HUP9901794A3/hu unknown
- 1997-06-18 CN CNB971955387A patent/CN1178648C/zh not_active Expired - Fee Related
- 1997-06-18 CA CA002257405A patent/CA2257405A1/en not_active Abandoned
- 1997-06-18 DE DE69725860T patent/DE69725860T2/de not_active Expired - Fee Related
- 1997-06-18 RU RU99101081/14A patent/RU2203662C2/ru not_active IP Right Cessation
- 1997-06-18 EE EE9800435A patent/EE04606B1/xx not_active IP Right Cessation
- 1997-06-18 PL PL97330910A patent/PL189716B1/pl not_active IP Right Cessation
1998
- 1998-12-09 RS YUP-566/98A patent/RS49590B/sr unknown
- 1998-12-13 IL IL127542A patent/IL127542A/en not_active IP Right Cessation
- 1998-12-15 IS IS4923A patent/IS2216B/is unknown
- 1998-12-18 NO NO19985964A patent/NO323295B1/no not_active IP Right Cessation
1999
- 1999-08-06 HK HK99103406A patent/HK1018590A1/xx not_active IP Right Cessation
2004
- 2004-06-18 US US10/871,506 patent/US20050113418A1/en not_active Abandoned
2006
- 2006-10-05 US US11/544,956 patent/US20070276007A1/en not_active Abandoned
2008
- 2008-09-30 US US12/242,006 patent/US20090036494A1/en not_active Abandoned

Also Published As

Publication number	Publication date
US20050113418A1 (en)	2005-05-26
CN1178648C (zh)	2004-12-08
NO985964D0 (no)	1998-12-18
PL189716B1 (pl)	2005-09-30
CZ298213B6 (cs)	2007-07-25
BR9709838A (pt)	1999-08-10
SE9602442D0 (sv)	1996-06-20
DE69725860D1 (de)	2003-12-04
NO323295B1 (no)	2007-03-05
CZ420398A3 (cs)	2000-02-16
HUP9901794A3 (en)	2002-11-28
HUP9901794A2 (hu)	2000-04-28
TR199802647T2 (xx)	1999-03-22
HK1018590A1 (en)	1999-12-30
US20070276007A1 (en)	2007-11-29
DK0921787T3 (da)	2004-02-23
PT921787E (pt)	2004-03-31
ES2208921T3 (es)	2004-06-16
SK284204B6 (sk)	2004-10-05
SK165598A3 (en)	1999-08-06
US20090036494A1 (en)	2009-02-05
RU2203662C2 (ru)	2003-05-10
EP0921787A1 (en)	1999-06-16
PL330910A1 (en)	1999-06-07
EE04606B1 (et)	2006-04-17
AU726859B2 (en)	2000-11-23
CN1222074A (zh)	1999-07-07
ATE252885T1 (de)	2003-11-15
NO985964L (no)	1999-02-22
RS49590B (sr)	2007-06-04
IS2216B (is)	2007-03-15
EE9800435A (et)	1999-06-15
WO1997048380A1 (en)	1997-12-24
CA2257405A1 (en)	1997-12-24
EP0921787B1 (en)	2003-10-29
AU3469097A (en)	1998-01-07
DE69725860T2 (de)	2004-09-09
UA64715C2 (en)	2004-03-15
IL127542A (en)	2006-08-01
IS4923A (is)	1998-12-15
NZ332990A (en)	2000-07-28
US20010008900A1 (en)	2001-07-19
JP2000512993A (ja)	2000-10-03
YU56698A (sh)	2004-12-31

Publication	Publication Date	Title
IL127542A0 (en)	1999-10-28	Administration regimen of H+ K+ -ATPase inhibitors
BG104619A (en)	2001-04-30	Oral pharmaceutical pulsed release dosage form
AP9701041A0 (en)	1999-01-10	Pyridylpyrrole compounds.
AU7239996A (en)	1997-04-09	Inhibition of tumor necrosis factor alpha
MX9800408A (es)	1998-04-30	Sales de derivados de amidina y de inhibidor de ciclooxigenasa, su procedimiento de preparacion, su aplicacion como medicamentos y composiciones farmaceuticas que los contienen.
EP1167354A3 (en)	2002-01-09	Racemic huperzine A
AU1306795A (en)	1995-07-10	Anticonvulsant pseudofructopyranose sulfamates
LV11728A (lv)	1997-04-20	Farmaceitiska kompozicija
UA42719C2 (uk)	2001-11-15	Сполуки, композиції та способи, які інгібують протеази, для лікування та профілактики імуномедіаторних запальних хвороб
MY133169A (en)	2007-10-31	Substituted heterocyclic benzocycloalkenes and the use thereof as substances having an analgesic effect
HK1018783A1 (en)	2000-01-07	BENZO[C]QUINOLIZINE DERIVATIVES, THEIR PREPARATION AND USE AS 5 α-REDUCTASES INHIBITORS
MD1744F2 (ro)	2001-09-30	Săruri ale acidului clavulanic şi procedeu de obţinere a lor
AU1604592A (en)	1992-12-03	New 2-amino-5-cyano-1,4-dihydropyridines, processes for their preparation and their use in medicaments
TW330933B (en)	1998-05-01	Furanoeremophilane and eremophilanolide sesquiterpenes for treatment of diabetes
MY115795A (en)	2003-09-30	Substituted benzenesulfonylureas and -thioureas, processes for their preparation and use of pharmaceutical preparations based on these compounds, and medicaments containing them
NO992225L (no)	1999-05-07	FremgangsmÕte for fremstilling av salter og estere av klavulansyre
AU6970394A (en)	1994-12-20	Desoxyazaphospholipid derivatives having inhibiting activity on phospholipase a2
IL112110A0 (en)	1995-03-15	Octahydro-1h-isoindoles and pharmaceutical compositions containing them
GB9323404D0 (en)	1994-01-05	Pharmaceuticals
PL318539A1 (en)	1997-06-23	Inhibition of biosynthesis
NZ503559A (en)	2002-12-20	Compositions and methods for the control of smoking containing a xanthine oxidase inhibitor
MX9804797A (es)	1998-10-31	Nuevos compuestos con efecto analgesico.
MX9804798A (es)	1998-10-31	Nuevos compuestos con efecto analgesico.
GB9323403D0 (en)	1994-01-05	Pharmaceuticals
MX9709438A (es)	1998-06-30	Ester-amidas de acido 3-hidroxi-piridina-2-carboxilico, su preparacion y su utilizacion como medicamentos.

Legal Events

Date	Code	Title	Description
2006-12-07	ERR	Corrigendum	Free format text: IN JOURNAL 4/2006 P. 1507 PATENT APPLICATION NO. 127542 CORRECT DATE OF APPLICATION TO- 18.06.1997
2006-12-27	FF	Patent granted
2007-03-08	KB	Patent renewed
2007-07-24	KB	Patent renewed